Individuals born preterm have an increased risk of death from birth through their third and fourth decades of life.
During the pandemic, older adults with migraine experienced a substantial increase in the risk for depression, regardless of previous history, than before the pandemic and compared with older adults ...
Poor control over specific aspects of work is associated with burnout among physicians, according to study findings.
COVID-19, influenza, and RSV vaccination coverage is low among nursing home residents early in the 2024 to 2025 season.
Eptinezumab vs placebo significantly reduces acute headache medication in patients with migraine and those with medication overuse.
Native American vs non-Hispanic White adults have higher rates of chronic pain, with psychosocial factors, such as stress, as a mediator for pain inequity.
A new PDUFA target date is April 30, 2025. The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for STS101 (dihydroergotamine [DHE] nasal powder) ...
Ketorolac significantly reduced postoperative pain and opioid requirements in adults who underwent lumbar spinal surgery.
High-dose nonsteroidal anti-inflammatory drug use among patients with axial spondyloarthritis (axSpA) may not increase the risk of developing hypertension, according to study results presented at the ...
High pain intensity among patients with axSpA around the world was linked to poor patient-reported outcomes, work impairment, and disease severity.
There are considerable differences in life expectancy between different groups within the US population, according to study findings.